Maplight Therapeutics, INC. (MPLT) — S-1/A Filings
All S-1/A filings from Maplight Therapeutics, INC.. Browse 1 S-1/A reports with AI-powered summaries and risk analysis.
S-1/A Filings (1)
-
MapLight Targets $250M IPO for CNS Pipeline, Schizophrenia Drug Leads
— Oct 6, 2025 Risk: high
MapLight Therapeutics, Inc. (MPLT) is launching its initial public offering of 14,750,000 shares at $17.00 per share, aiming to raise $250,750,000 before underw
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX